GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bionomics Ltd (OTCPK:BNOEF) » Definitions » EV-to-EBITDA

Bionomics (Bionomics) EV-to-EBITDA : (As of May. 06, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Bionomics EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bionomics's enterprise value is $-10.56 Mil. Bionomics's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil. Therefore, Bionomics's EV-to-EBITDA for today is .

The historical rank and industry rank for Bionomics's EV-to-EBITDA or its related term are showing as below:

BNOEF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -64.25   Med: -8.28   Max: 56.09
Current: 0.5

During the past 13 years, the highest EV-to-EBITDA of Bionomics was 56.09. The lowest was -64.25. And the median was -8.28.

BNOEF's EV-to-EBITDA is ranked better than
79.48% of 458 companies
in the Biotechnology industry
Industry Median: 9.535 vs BNOEF: 0.50

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-06), Bionomics's stock price is $0.006. Bionomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.008. Therefore, Bionomics's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Bionomics EV-to-EBITDA Historical Data

The historical data trend for Bionomics's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionomics EV-to-EBITDA Chart

Bionomics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.65 -24.58 -27.26 -1.67 -0.28

Bionomics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -0.28 -

Competitive Comparison of Bionomics's EV-to-EBITDA

For the Biotechnology subindustry, Bionomics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bionomics's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bionomics's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bionomics's EV-to-EBITDA falls into.



Bionomics EV-to-EBITDA Calculation

Bionomics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=-10.561/0
=

Bionomics's current Enterprise Value is $-10.56 Mil.
Bionomics's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bionomics  (OTCPK:BNOEF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bionomics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.006/-0.008
=At Loss

Bionomics's share price for today is $0.006.
Bionomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.008.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Bionomics EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bionomics's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bionomics (Bionomics) Business Description

Traded in Other Exchanges
Address
200 Greenhill Road, Eastwood, SA, AUS, 5063
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.